Cargando…
Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine
Tuberous sclerosis complex (TSC) is a rare genetic disorder caused by mutations in the TSC1 or TSC2 genes, which encode proteins that antagonise the mammalian isoform of the target of rapamycin complex 1 (mTORC1) – a key mediator of cell growth and metabolism. TSC is characterised by the development...
Autores principales: | Schubert-Bast, Susanne, Strzelczyk, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290505/ https://www.ncbi.nlm.nih.gov/pubmed/34349839 http://dx.doi.org/10.1177/17562864211031100 |
Ejemplares similares
-
Autism and Epilepsy in Patients With Tuberous Sclerosis Complex
por: Specchio, Nicola, et al.
Publicado: (2020) -
Editorial: Burden of Illness in People With Epilepsy: From Population-Based Studies to Precision Medicine
por: Strzelczyk, Adam, et al.
Publicado: (2019) -
A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)
por: Zöllner, Johann Philipp, et al.
Publicado: (2020) -
The Putative Role of mTOR Inhibitors in Non-tuberous Sclerosis Complex-Related Epilepsy
por: Goldstein, Hannah E., et al.
Publicado: (2021) -
Ketogenic Diet Therapy for Drug-Resistant Epilepsy and Cognitive Impairment in Children With Tuberous Sclerosis Complex
por: Fang, Yu, et al.
Publicado: (2022)